GM2 Gangliosidosis: Whole-Exome Sequencing Reveals Novel Homozygous Pathogenic Variant within the HEXA Gene in Iranian Family

Z. Zargar,M. Maleknia,M. Sabzeghabaiean,J. Mohammadi-Asl,F. Golab,M. Naseroleslami
DOI: https://doi.org/10.1134/s1022795424010125
2024-03-12
Russian Journal of Genetics
Abstract:GM2 gangliosidosis is a hereditary lysosomal storage disorder resulting from mutations in the Hexosaminidase A (HEXA) gene, which leads to a deficiency in the activity of the β HEXA isoenzyme. This condition is characterized by the accumulation of GM2 ganglioside within the lysosomes, which subsequently induces neurological consequences. This study sought to find causal variations in a consanguineous family with two affected children strongly suspected of GM2 gangliosidosis and a 17-week fetus. We conducted whole-exome sequencing (WES) on the genomic DNA of the proband to identify the causative variants. Subsequently, we performed confirmation and co-segregation analysis of the identified variant with the phenotype in the proband, fetus, and family members using Sanger sequencing. Also, cytogenetic evaluation was performed using amniocentesis to identify fetal chromosomal abnormalities. After conducting bioinformatic analysis and applying data filtering techniques, we found a novel homozygous variation [NM_000520.6:c.1378T>C:p.W460R] within the HEXA gene. The identified variant was further confirmed through Sanger sequencing in the proband and segregated with GM2 gangliosidosis and infantile Tay-Sachs disease (TSD) in the family. The single alteration was pathogenic and considered a missense variant that altered the protein features by substituting the highly conserved amino acid tryptophan with arginine at position 460 in the HEXA protein sequence. The findings of this study offer additional support for the genetic heterogeneity of GM2 gangliosidosis and broaden the mutational gene spectrum of this inherited metabolic disorder by finding a novel HEXA pathogenic variant that had not previously been reported in these patients.
genetics & heredity
What problem does this paper attempt to address?